Combination iSTAT/Alinity and IR Oculography for Head CT Necessity and Recovery Prediction After mTBI

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07094230

Enrollment

Registered

2025-07-30

Start date

2025-08-01

Completion date

2026-08-31

Last updated

2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood

Keywords

mTBI, biomarkers, IR Oculography

Brief summary

Use of blood biomarkers and eye tracking after traumatic brain injury for recovery timeline prediction

Detailed description

Use of blood biomarkers and video IR oculography after mTBI for necessity of head CT scan and recovery timeline prediction

Interventions

DIAGNOSTIC_TESTbiomarkers analyses

blood analyses

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

Patients aged 18-85, Communicative in English language, With clinician-confirmed mTBI (GCS 13-15, ≤24 hours post-injury)

Exclusion criteria

Neurological, vestibular, or visual disorders, Significant comorbidities, Prior TBI (\<6 months) Special populations (pregnant, incarcerated, active-duty recruits). Active-duty recruits excluded due to inability to contact them at scheduled intervals for remote follow-up questionnaires. \-

Design outcomes

Primary

Measure	Time frame	Description
blood biomarkers analyses	same day	Alinity device analyses of GFAP and UCH-L1

Countries

United States

Contacts

Primary ContactBharathi Swaminathan, MD

Bharathi.Swaminathan2@va.gov224-610-4152

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026